Drugs / PBK-1801
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT04418388 | Oct → Dec 2019 | — | Pharmbio Korea Co., Ltd. | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | PBK-1801 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04418388 ↗ |
| Route | Oral | “Administered orally” NCT04418388 ↗ |